Flamel Technologies

Manufacturing · France · 51-200 Employees

View Company Info for Free

Overview

Headquarters

Parc Club Du Moulin 33 À Vent, Venissieu...

Phone Number

+33 472783434

Revenue

$75.4 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Flamel Technologies

Flamel Technologies SA's ( NASDAQ : FLML ) business model is to blend high-value internally developed products with its leading drug delivery capabilities. The company markets Bloxiverz (neostigmine methylsulfate) in the USA and manufactures Micropump-based microparticles under FDA-audited GMP guidelines for Coreg CR® (carvedilol phosphate), marketed in the USA by GlaxoSmithKline. The Company has a proprietary pipeline of niche specialty pharmaceutical products, while its drug delivery platforms are focused on the goal of developing safer, more efficacious formulations of drugs to address unmet medical needs. Its pipeline includes chemical and biological drugs formulated with its Micropump® (and its applications to the development of liquid formulations LiquiTime® and of abuse-deterrent formulations Trigger Lock) and Medusa proprietary drug delivery platforms. Several Medusa-based products have been successfully tested in clinical trials. The Company is headquartered in Lyon, France anRead more
Flamel Technologies's Social MediaPopular SearchesFlamel technologies SAFlamel TechnologiesFlamel Technologies IncFlamel Technologies, Eclatc Flamel technologies SASIC Code 28,283NAICS Code 32,325Show more

Flamel Technologies Org Chart

PhoneEmail
DE
France flag for contact location.

Supply Chain Analyst

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Flamel Technologies your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Flamel Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Flamel Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Flamel Technologies.

Flamel Technologies financials insights

Gather financial insights about Flamel Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2013

Debt

$15M

See All Flamel Technologies's Financials Insights

Flamel Technologies Tech Stack

A closer look at the technologies used by Flamel Technologies

Top Manufacturing Companies

Frequently Asked Questions Regarding Flamel Technologies

What is Flamel Technologies's official website?
Flamel Technologies's official website is www.flamel.com
What is Flamel Technologies's Revenue?
Flamel Technologies's revenue is $75.4 Million
What is Flamel Technologies's SIC code?
Flamel Technologies's SIC: 28,283
What is Flamel Technologies's NAICS code?
Flamel Technologies's NAICS: 32,325
How many employees does Flamel Technologies have?
Flamel Technologies has 51-200 employees
What industry does Flamel Technologies belong to?
Flamel Technologies is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What companies has Flamel Technologies acquired?
Flamel Technologies has acquired the companies: Eclat Pharmaceuticals
What technology does Flamel Technologies use?
Some of the popular technologies that Flamel Technologies uses are: Microsoft Azure, GoDaddy SSL Certificates, Microsoft Azure DNS
How do I contact Flamel Technologies?
Flamel Technologies contact info: Phone number: +33 472783434 Website: www.flamel.com
What does Flamel Technologies do?

Flamel Technologies SA's ( NASDAQ : FLML ) business model is to blend high-value internally developed products with its leading drug delivery capabilities. The company markets Bloxiverz (neostigmine methylsulfate) in the USA and manufactures Micropump-based microparticles under FDA-audited GMP guidelines for Coreg CR® (carvedilol phosphate), market... ed in the USA by GlaxoSmithKline. The Company has a proprietary pipeline of niche specialty pharmaceutical products, while its drug delivery platforms are focused on the goal of developing safer, more efficacious formulations of drugs to address unmet medical needs. Its pipeline includes chemical and biological drugs formulated with its Micropump® (and its applications to the development of liquid formulations LiquiTime® and of abuse-deterrent formulations Trigger Lock) and Medusa proprietary drug delivery platforms. Several Medusa-based products have been successfully tested in clinical trials. The Company is headquartered in Lyon, France and has operations in St. Louis, Missouri, USA, and manufacturing facilities in Pessac, France.Read More

What are Flamel Technologies social media links?
Flamel Technologies Linkedin page
Is Flamel Technologies a public company?
Flamel Technologies is private company therefore does not currently have an official ticker symbol
See more information about Flamel Technologies

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.